64 related articles for article (PubMed ID: 8096384)
21. Addition of an extra immunoglobulin domain to two anti-rodent TNF monoclonal antibodies substantially increased their potency.
Scallon B; Cai A; Radewonuk J; Naso M
Mol Immunol; 2004 May; 41(1):73-80. PubMed ID: 15140577
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies.
Mukherjee J; Kozel TR; Casadevall A
J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877
[TBL] [Abstract][Full Text] [Related]
23. Development of a trispecific antibody conjugate that directs two distinct tumor-associated antigens to CD64 on myeloid effector cells.
Somasundaram C; Sundarapandiyan K; Keler T; Deo YM; Graziano RF
Hum Antibodies; 1999; 9(1):47-54. PubMed ID: 10331185
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the fibrin binding profile of two anti-fibrin monoclonal antibodies.
Raut S; Gaffney PJ
Thromb Haemost; 1996 Jul; 76(1):56-64. PubMed ID: 8819252
[TBL] [Abstract][Full Text] [Related]
25. The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease.
Zhang L; French RR; Chan HT; O'Keefe TL; Cragg MS; Power MJ; Glennie MJ
Ther Immunol; 1995 Aug; 2(4):191-202. PubMed ID: 9358611
[TBL] [Abstract][Full Text] [Related]
26. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
27. Alterations of specific and nonspecific binding of monoclonal antibody by introduction of acidic and hydrophobic groups.
Wang J; Masuko T; Ueno H; Hashimoto Y
Biol Pharm Bull; 1994 Jun; 17(6):831-5. PubMed ID: 7951148
[TBL] [Abstract][Full Text] [Related]
28. Rat monoclonal antibodies to the external domain of the product of the C-erbB-2 proto-oncogene.
Styles JM; Harrison S; Gusterson BA; Dean CJ
Int J Cancer; 1990 Feb; 45(2):320-4. PubMed ID: 1689275
[TBL] [Abstract][Full Text] [Related]
29. Scintigraphic detection of overexpressed c-erbB-2 protooncogene products by a class-switched murine anti-c-erbB-2 protein monoclonal antibody.
Saga T; Endo K; Akiyama T; Sakahara H; Koizumi M; Watanabe Y; Nakai T; Hosono M; Yamamoto T; Toyoshima K
Cancer Res; 1991 Feb; 51(3):990-4. PubMed ID: 1671001
[TBL] [Abstract][Full Text] [Related]
30. A novel photoactivatable cross-linker for the functionally-directed region-specific fluorescent labeling of proteins.
Thevenin BJ; Shahrokh Z; Williard RL; Fujimoto EK; Kang JJ; Ikemoto N; Shohet SB
Eur J Biochem; 1992 Jun; 206(2):471-7. PubMed ID: 1597185
[TBL] [Abstract][Full Text] [Related]
31. Antigen forks: bispecific reagents that inhibit cell growth by binding selected pairs of tumor antigens.
Ring DB; Hsieh-Ma ST; Shi T; Reeder J
Cancer Immunol Immunother; 1994 Jul; 39(1):41-8. PubMed ID: 8044825
[TBL] [Abstract][Full Text] [Related]
32. Antigen protection of monoclonal antibodies undergoing labelling.
Ramjeesingh M; Zywulko M; Rothstein A; Whyte R; Shami EY
J Immunol Methods; 1990 Oct; 133(2):159-67. PubMed ID: 2230135
[TBL] [Abstract][Full Text] [Related]
33. The use of sulfosuccinimidyl-2-(p-azidosalicylamido)-1,3'-dithiopropionate as a crosslinking reagent to identify cell surface receptors.
Shephard EG; de Beer FC; von Holt C; Hapgood JP
Anal Biochem; 1988 Feb; 168(2):306-13. PubMed ID: 3364730
[TBL] [Abstract][Full Text] [Related]
34. A murine monoclonal antibody that recognizes an extracellular domain of the human c-erbB-2 protooncogene product.
Masuko T; Sugahara K; Kozono M; Otsuki S; Akiyama T; Yamamoto T; Toyoshima K; Hashimoto Y
Jpn J Cancer Res; 1989 Jan; 80(1):10-4. PubMed ID: 2565325
[TBL] [Abstract][Full Text] [Related]
35. Preparation and characterization of 4-azido-2-nitrophenyl human serum albumin as an antigen for covalent cross-linking of immune complexes.
Mannik M; David KA; Gauthier VJ
J Immunol; 1981 Nov; 127(5):1993-9. PubMed ID: 6795265
[TBL] [Abstract][Full Text] [Related]
36. A critical comparison of three internalization assays applied to the evaluation of a given mAb as a toxin-carrier candidate.
Casalini P; Caldera M; Canevari S; Ménard S; Mezzanzanica D; Tosi E; Gadina M; Colnaghi MI
Cancer Immunol Immunother; 1993 Jul; 37(1):54-60. PubMed ID: 8099847
[TBL] [Abstract][Full Text] [Related]
37. Probing Antibody Binding Sites on G Protein-Coupled Receptors Using Genetically Encoded Photo-Activatable Cross-Linkers.
Huber T; Sakmar TP
Methods Mol Biol; 2018; 1785():65-75. PubMed ID: 29714012
[TBL] [Abstract][Full Text] [Related]
38. Covalent and Oriented Surface Immobilization of Antibody Using Photoactivatable Antibody Fc-Binding Protein Expressed in Escherichia coli.
Lee Y; Jeong J; Lee G; Moon JH; Lee MK
Anal Chem; 2016 Oct; 88(19):9503-9509. PubMed ID: 27577011
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of immunoconjugates for antibody-targeted photolysis.
Rakestraw SL; Tompkins RG; Yarmush ML
Bioconjug Chem; 1990; 1(3):212-21. PubMed ID: 1710935
[TBL] [Abstract][Full Text] [Related]
40. Concise synthesis of ciguatoxin ABC-ring fragments and surface plasmon resonance study of the interaction of their BSA conjugates with monoclonal antibodies.
Nagumo Y; Oguri H; Shindo Y; Sasaki S; Oishi T; Hirama M; Tomioka Y; Mizugaki M; Tsumuraya T
Bioorg Med Chem Lett; 2001 Aug; 11(15):2037-40. PubMed ID: 11454475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
